Pfizer Expands in Infectious Disease Market with Amplyx’s Acquisition
On April 28th, Pfizer announced that it has bought the privately held infectious disease biotech Amplyx Pharmaceuticals for an undisclosed sum. From the deal, Pfizer is expected to gain a …
Read More